Skip to main content
EarningsCallAI
PFE

Pfizer Inc.

Healthcare

NEUTRAL(HIGH)

Operator Signal: NEUTRAL

Steady-state performance. No major expansion or contraction signals, business as usual.

$14.5B
Latest Revenue
-18.4%
Revenue Growth (YoY)
$0.47
Latest EPS
$2.7B
Latest Net Income

Quarterly Earnings History

QuarterRevenueNet IncomeEPS
Q1 2026$14.5B$2.7B$0.47
Q3 2025$16.7B$3.5B$0.62
Q2 2025$14.7B$2.9B$0.51
Q1 2025$13.7B$3.0B$0.52
Q3 2024$17.7B$4.5B$0.78
Q2 2024$13.3B$41.0M$0.01
Q1 2024$14.9B$3.1B$0.55
Q3 2023$13.5B$2.3B$0.41

What This Means for Operators

Pfizer Inc. is in steady-state mode. Revenue is relatively flat quarter-over-quarter, which means no major expansion or contraction signals. Business as usual.

Steady doesn't mean irrelevant. PFE's stability tells you the underlying market is mature. If you're building in this space, growth will come from taking share, not riding a wave.

Data from SEC EDGAR. View original filings: Pfizer Inc. SEC Filings

Frequently Asked Questions

Pfizer Inc. (PFE) currently has a NEUTRAL operator signal with HIGH confidence. This signal is based on quarterly revenue trends and earnings patterns across 8 quarters of data.

Pfizer Inc.'s latest reported revenue is $14.5B, representing -18.4% year-over-year growth. Latest EPS was $0.47.

Based on 8 quarters of earnings data, Pfizer Inc. shows a NEUTRAL signal. Revenue is relatively flat, indicating stability.

Pfizer Inc.'s quarterly (10-Q) and annual (10-K) filings are available on SEC EDGAR. We analyze these filings to extract revenue, EPS, and net income data for our operator signal calculations.

Sources: SEC EDGAR
Last updated:

Operator signals are derived from quarterly revenue trends, EPS patterns, and net income direction across multiple quarters. Signals indicate momentum direction, not stock recommendations.